PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55,208,568 | -18.2% | 1,799,497 | +6.8% | 0.61% | -6.2% |
| Q2 2023 | $67,528,168 | +3.2% | 1,685,255 | +5.1% | 0.65% | -4.4% |
| Q1 2023 | $65,462,668 | +59.7% | 1,604,084 | +51.1% | 0.68% | +51.8% |
| Q4 2022 | $40,981,542 | -32.1% | 1,061,423 | -6.5% | 0.45% | -37.0% |
| Q3 2022 | $60,370,000 | -2.6% | 1,134,987 | +6.8% | 0.71% | -0.7% |
| Q2 2022 | $61,953,000 | -23.0% | 1,062,667 | +0.8% | 0.71% | -2.2% |
| Q1 2022 | $80,496,000 | +43.9% | 1,054,722 | +13.4% | 0.73% | +64.9% |
| Q4 2021 | $55,950,000 | +25.8% | 929,871 | +17.1% | 0.44% | +26.6% |
| Q3 2021 | $44,461,000 | -9.8% | 793,944 | -2.2% | 0.35% | -3.3% |
| Q2 2021 | $49,277,000 | -32.3% | 812,073 | -21.8% | 0.36% | -34.5% |
| Q1 2021 | $72,780,000 | +17.8% | 1,038,375 | +0.6% | 0.55% | +20.6% |
| Q4 2020 | $61,767,000 | -5.2% | 1,032,197 | -4.8% | 0.46% | -19.7% |
| Q3 2020 | $65,176,000 | +12.4% | 1,084,098 | -1.9% | 0.57% | +10.9% |
| Q2 2020 | $57,963,000 | +60.1% | 1,104,691 | +2.3% | 0.51% | +26.0% |
| Q1 2020 | $36,201,000 | -40.8% | 1,079,672 | -20.0% | 0.41% | -10.0% |
| Q4 2019 | $61,139,000 | -4.3% | 1,349,649 | -19.6% | 0.45% | -9.6% |
| Q3 2019 | $63,900,000 | -9.0% | 1,678,484 | +3.9% | 0.50% | -5.7% |
| Q2 2019 | $70,231,000 | +33.8% | 1,614,871 | +17.1% | 0.53% | +42.1% |
| Q1 2019 | $52,509,000 | +788.8% | 1,379,625 | +1013.9% | 0.37% | +767.4% |
| Q2 2017 | $5,908,000 | +2.1% | 123,857 | -2.4% | 0.04% | 0.0% |
| Q1 2017 | $5,787,000 | +127.6% | 126,915 | +61.2% | 0.04% | +115.0% |
| Q4 2016 | $2,543,000 | -11.3% | 78,736 | -6.0% | 0.02% | -13.0% |
| Q3 2016 | $2,866,000 | -16.9% | 83,748 | -18.1% | 0.02% | -17.9% |
| Q2 2016 | $3,449,000 | -60.7% | 102,244 | -38.2% | 0.03% | -60.0% |
| Q1 2016 | $8,766,000 | -39.8% | 165,462 | -12.8% | 0.07% | -42.1% |
| Q4 2015 | $14,571,000 | – | 189,746 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |